Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
TRAW Traws Pharma
- 4.650
- -0.190-3.92%
Close Dec 13 16:00 ET
14.07MMarket Cap-0.03P/E (TTM)
4.710High4.619Low4.32KVolume4.670Open4.840Pre Close20.23KTurnover0.19%Turnover RatioLossP/E (Static)3.03MShares27.50052wk High-6.92P/B10.62MFloat Cap4.06052wk Low--Dividend TTM2.28MShs Float1751062.500Historical High--Div YieldTTM1.88%Amplitude4.060Historical Low4.678Avg Price1Lot Size
About Traws Pharma Company
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
Company Profile
SymbolTRAW
Company NameTraws Pharma
Listing DateJul 25, 2013
Founded1998
CEOMr. Werner Cautreels PhD
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address12 Penns Trail
CityNewtown
ProvincePennsylvania
CountryUnited States of America
Zip Code18940-3423
Phone1-267-759-3680
Websitehttp://www.trawspharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Werner Cautreels, PhD
- Director and Chief Executive Officer
- --
- Dr. Victor M. Moyo, M.D.
- Chief Medical Officer, Oncology
- 405.24K
- Mark P. Guerin
- Chief Financial Officer and Principal Accounting Officer
- 745.52K
- Dr. Nikolay Savchuk
- Director and Chief Operating Officer
- --
- Dr. Charles David Pauza, PhD
- Chief Scientific Officer, Virology
- --
- Dr. Robert Redfield
- Chief Medical Officer
- --
- Dr. Iain D. Dukes, D.Phil.
- Executive Chairman of the Board
- --
- Luba Greenwood
- Director
- --
- Jack E. Stover
- Independent Director
- 126.72K
- Mary Teresa Shoemaker
- Independent Director
- 118.22K
- Dr. Trafford Clarke, PhD
- Independent Director
- 104.22K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.